Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04857424 · ClinicalTrials.gov registry record

Quality of Life Assessment Between Internal Endoscopic Versus Percutaneous Drainage in Biliary Obstruction

A clinical trial of Biliary Obstruction, sponsored by Mayo Clinic.

Active
Registry status
206
Enrollment target
1
Study location

NCT04857424: Active study of Biliary Obstruction, sponsored by Mayo Clinic.

NCT04857424 is a study of Biliary Obstruction that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 206 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04857424, a study of Biliary Obstruction, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
206 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to compare the quality of life in subjects with benign and malignant biliary obstruction who have or will undergo endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous trans-hepatic biliary drainage (PTBD).

Primary Outcome

Measured using the European Quality of Life-5 Dimensions questionnaire that measures mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The Euro-QOL-5D score is derived from adding the scores from each of the five items. The best possible score is five (i.e., asymptomatic in each item) and the worst possible score is 15 (incapacitated in each item).

Conditions Studied

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2021-07-15
Est. Completion 2026-03-31
Mayo Clinic

2,844 total trials

What the registry record for NCT04857424 still lists

NCT04857424 is an observational study that tracks outcomes without assigning an intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Biliary Obstruction appearing as the primary indexed condition, and to 0 interventions.

NCT04857424 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04857424 about?

NCT04857424 is a clinical study titled "Quality of Life Assessment Between Internal Endoscopic Versus Percutaneous Drainage in Biliary Obstruction". The aim of this study is to compare the quality of life in subjects with benign and malignant biliary obstruction who have or will undergo endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous trans-hepatic biliary drainage (PTBD).

What is the current status of trial NCT04857424?

This trial is currently active not recruiting. The enrollment target is 206 participants. The study started on 2021-07-15. Estimated completion is 2026-03-31.

What conditions does trial NCT04857424 study?

This clinical trial studies the following conditions: Biliary Obstruction.

Who is sponsoring clinical trial NCT04857424?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04857424 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Biliary Obstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03373968 · 206 participants · Phase 2

    Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  • NCT03550391 · 206 participants · Phase 3

    Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • NCT04757116 · 206 participants · NA

    Post-Market Study to Assess iTind Safety in Comparison to UroLift

  • NCT05675865 · 206 participants · NA

    Cryoablation for Monomorphic Ventricular Tachycardia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04857424, the US trial registry maintained by the National Library of Medicine. NCT04857424 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.